×

Shareholder Information

Company information

Registered name: e-therapeutics plc
Country of incorporation: England and Wales
Main country of operation: UK
Company number: 04304473
Registered office: 17 Blenheim Office Park, Long Hanborough Oxfordshire, OX29 8LN

Listing

e-Therapeutics is listed on the Alternative Investment Market of the London Stock Exchange (AIM), with ticker symbol ETX.

The Company has not applied or agreed to have any of its securities (including its AIM securities) admitted to or traded on any other exchanges or trading platforms.

Securities in issue

Number of AIM securities in issue: 514,553,598 ordinary shares of 0.1p
Percentage of AIM securities not in public hands: 52.34%
Listing: AIM
Index: FTSE AIM All Share
Sector: Pharmaceutical & Biotechnology
Symbol: ETX

There are no restrictions on the transfer of the Company’s shares.

Last updated: 06 July 2021

Significant Shareholdings

  • Richard Griffiths and controlled undertakings – 143,539,105 (27.90%)
  • Ali Mortazavi - 50,666,666 (9.85%)
  • Robert Quested - 49,484,948 (9.62%)
  • M&G - 34,375,000 (6.68%)
  • Trillian Ltd - 30,454,847 (5.92%)
  • Lombard Odier Asset Management – 18,082,221 (3.51%)

Last updated: 26 July 2021

Advisors

Nominated advisor and broker
SP Angel Corporate Finance LLP
Prince Frederick House
35-39 Maddox Street
London
W1S 2PP
020 3470 0470
www.spangel.co.uk

Auditors
Grant Thornton UK LLP
30 Finsbury Square
London
EC2A 1AG
www.grantthornton.co.uk

Bankers
Bank of Scotland
PO Box No 10
38 St. Andrews Square
Edinburgh
EH2 2AD
Tel: +44 (0) 131 465 3900
www.bankofscotland.co.uk

Solicitors
Stephenson Harwood LLP
1 Finsbury Circus
London
EC2M 7SH
Tel: +44 (0) 20 7329 4422
www.shlegal.com

Registrars
Neville Registrars Limited
Neville House
18 Laurel Lane
Halesowen
West Midlands
B63 3DA
Tel: +44 (0) 121 585 1131
Fax: +44 (0) 121 585 1132
www.nevilleregistrars.co.uk

Scroll to Top